Allogeneic bone marrow transplantation for poor-prognosis lymphoma: response, toxicity and survival depend on disease histology.

[1]  B. Andersson,et al.  Allogeneic bone marrow transplantation for refractory and recurrent low-grade lymphoma: the case for aggressive management. , 1995, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[2]  K. van Besien,et al.  High-dose chemotherapy with BEAC regimen and autologous bone marrow transplantation for intermediate grade and immunoblastic lymphoma: durable complete remissions, but a high rate of regimen-related toxicity. , 1995, Bone marrow transplantation.

[3]  A. Deisseroth,et al.  Allogeneic blood stem cell transplantation for refractory leukemia and lymphoma: Potential advantage of blood over marrow allografts , 1995 .

[4]  K. van Besien,et al.  High-dose melphalan allows durable engraftment of allogeneic bone marrow. , 1995, Bone marrow transplantation.

[5]  J. Gribben,et al.  Pivotal role of the B7:CD28 pathway in transplantation tolerance and tumor immunity. , 1994, Blood.

[6]  K. van Besien,et al.  Etoposide, cyclophosphamide, total-body irradiation, and allogeneic bone marrow transplantation for hematologic malignancies. , 1994, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[7]  H Stein,et al.  A revised European-American classification of lymphoid neoplasms: a proposal from the International Lymphoma Study Group. , 1994, Blood.

[8]  A. Goldstone,et al.  High-dose therapy and autologous bone marrow transplantation for adult patients with lymphoblastic lymphoma: results of the European Group for Bone Marrow Transplantation. , 1994, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[9]  S. Tucker,et al.  ESHAP--an effective chemotherapy regimen in refractory and relapsing lymphoma: a 4-year follow-up study. , 1994, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[10]  M. Dimopoulos,et al.  Allogeneic bone marrow transplantation for leukemia following piperazinedione and fractionated total body irradiation , 1994, American journal of hematology.

[11]  A. Norton,et al.  Myeloablative therapy with autologous bone marrow transplantation as consolidation therapy for recurrent follicular lymphoma. , 1994, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[12]  A. Deisseroth,et al.  A phase I-II study of high-dose thiotepa, busulfan and cyclophosphamide as a preparative regimen for allogeneic marrow transplantation. , 1994, Bone marrow transplantation.

[13]  E. Abella,et al.  Prospective comparative trial of autologous versus allogeneic bone marrow transplantation in patients with non-Hodgkin's lymphoma. , 1994, Blood.

[14]  M. A. Tanner,et al.  One hundred autotransplants for relapsed or refractory Hodgkin's disease and lymphoma: value of pretransplant disease status for predicting outcome. , 1993, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[15]  J. Armitage,et al.  High-dose chemotherapy and autologous hematopoietic stem-cell transplantation for aggressive non-Hodgkin's lymphoma. , 1993, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[16]  A. Freedman.  Expression and function of adhesion receptors on normal B cells and B cell non-Hodgkin's lymphomas. , 1993, Seminars in hematology.

[17]  A. Freedman,et al.  Which patients with relapsed non-Hodgkin's lymphoma benefit from high-dose therapy and hematopoietic stem-cell transplantation? , 1993, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[18]  M. Strawderman,et al.  Prognostic factors for treatment outcome in autotransplantation of intermediate-grade and high-grade non-Hodgkin's lymphoma with cyclophosphamide, carmustine, and etoposide. , 1993, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[19]  T M Grogan,et al.  Comparison of a standard regimen (CHOP) with three intensive chemotherapy regimens for advanced non-Hodgkin's lymphoma. , 1993, The New England journal of medicine.

[20]  J. Armitage,et al.  Treatment of non-Hodgkin's lymphoma. , 1993, The New England journal of medicine.

[21]  G. Pinkus,et al.  Intermediate lymphocytic lymphoma: clinical and pathologic features of a recently characterized subtype of non-Hodgkin's lymphoma. , 1993, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[22]  W. Velasquez,et al.  CHOP-Bleo plus interferon for stage IV low-grade lymphoma. , 1993, Annals of oncology : official journal of the European Society for Medical Oncology.

[23]  D. Longo,et al.  What's the deal with follicular lymphomas? , 1993, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[24]  G. Schoch,et al.  Ganciclovir Prophylaxis To Prevent Cytomegalovirus Disease after Allogeneic Marrow Transplant , 1993, Annals of Internal Medicine.

[25]  M. Oken,et al.  Interferon alfa combined with cytotoxic chemotherapy for patients with non-Hodgkin's lymphoma. , 1992, The New England journal of medicine.

[26]  L. Gordon,et al.  Comparison of a second-generation combination chemotherapeutic regimen (m-BACOD) with a standard regimen (CHOP) for advanced diffuse non-Hodgkin's lymphoma. , 1992, The New England journal of medicine.

[27]  R. Chopra,et al.  Autologous versus allogeneic bone marrow transplantation for non-Hodgkin's lymphoma: a case-controlled analysis of the European Bone Marrow Transplant Group Registry data. , 1992, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[28]  R. Levy,et al.  Induction of immune responses in patients with B-cell lymphoma against the surface-immunoglobulin idiotype expressed by their tumors. , 1992, The New England journal of medicine.

[29]  J. L. Goodman,et al.  A controlled trial of fluconazole to prevent fungal infections in patients undergoing bone marrow transplantation. , 1992, The New England journal of medicine.

[30]  J. Bosq,et al.  Burkitt's lymphoma in adults: a retrospective study of 46 cases. , 1992, Nouvelle revue francaise d'hematologie.

[31]  C. Lawton,et al.  Allogeneic bone marrow transplantation for relapsed and refractory lymphoma using genotypically HLA-identical and alternative donors. , 1991, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[32]  D. Neuberg,et al.  Autologous bone marrow transplantation in 69 patients with a history of low-grade B-cell non-Hodgkin's lymphoma. , 1991, Blood.

[33]  S. Piantadosi,et al.  Evidence of a graft-versus-lymphoma effect associated with allogeneic bone marrow transplantation. , 1991, Blood.

[34]  K. Sullivan,et al.  Immunomodulatory and antimicrobial efficacy of intravenous immunoglobulin in bone marrow transplantation. , 1990, The New England journal of medicine.

[35]  A. Rimm,et al.  Risk factors for chronic graft-versus-host disease after HLA-identical sibling bone marrow transplantation. , 1990, Blood.

[36]  X. Troussard,et al.  Allogeneic bone marrow transplantation in adults with Burkitt's lymphoma or acute lymphoblastic leukemia in first complete remission. , 1990, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[37]  P. Colombat,et al.  The role of autologous bone marrow transplantation in 46 adult patients with non-Hodgkin's lymphomas. , 1990, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[38]  K. Sullivan,et al.  Autologous marrow transplantation for malignant lymphoma: a report of 101 cases from Seattle. , 1990, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[39]  H. Lazarus,et al.  The Treatment of Progressive Non-Hodgkin's Lymphoma With Intensive Chemoradiotherapy and Autologous Marrow Transplantation , 1990 .

[40]  E. Copelan,et al.  Allogeneic marrow transplantation in non-Hodgkin's lymphoma. , 1990, Bone marrow transplantation.

[41]  K. Sullivan,et al.  High-dose cytosine arabinoside, total body irradiation and marrow transplantation for advanced malignant lymphoma. , 1989, Bone marrow transplantation.

[42]  Hu Yf,et al.  Fetal islet cell transplantation in China. , 1989 .

[43]  D. Weisenburger,et al.  Allogeneic bone marrow transplantation in patients with lymphoma relapsing after autologous marrow transplantation. , 1989, Bone marrow transplantation.

[44]  N. Schmitz,et al.  Fractionated total body irradiation and high-dose VP 16-213 followed by allogeneic bone marrow transplantation in advanced leukemias. , 1988, Blood.

[45]  H. Deeg,et al.  Treatment of malignant lymphoma in 100 patients with chemotherapy, total body irradiation, and marrow transplantation. , 1987, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[46]  K. Anderson,et al.  Prolonged disease-free survival after autologous bone marrow transplantation in patients with non-Hodgkin's lymphoma with a poor prognosis. , 1987, The New England journal of medicine.

[47]  J. Armitage,et al.  High-dose therapy and autologous bone marrow transplantation after failure of conventional chemotherapy in adults with intermediate-grade or high-grade non-Hodgkin's lymphoma. , 1987, The New England journal of medicine.

[48]  L. R. Hill,et al.  A prospective randomized study of acute graft-v-host disease in 107 patients with leukemia: methotrexate/prednisone v cyclosporine A/prednisone. , 1987, Transplantation proceedings.

[49]  S. Jagannath,et al.  High-dose melphalan and total body irradiation with bone marrow transplantation for refractory malignancies. , 1986, European journal of cancer & clinical oncology.

[50]  P. Ljungman,et al.  Marrow transplantation for non-Hodgkin's lymphoma: a multi-centre study from the European Co-operative Bone Marrow Transplant Group. , 1986, Bone marrow transplantation.

[51]  J. Fay,et al.  High-dose chemotherapy, fractionated total-body irradiation, and allogeneic marrow transplantation for malignant lymphoma. , 1986, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[52]  A. Goldstone,et al.  Clinical studies of ABMT in non-Hodgkin's lymphoma. , 1986, Clinics in haematology.

[53]  H. Deeg,et al.  Treatment of non‐Hodgkin's lymphoma with chemoradiotherapy and allogenic marrow transplantation , 2007, Hematological oncology.

[54]  P. Neiman,et al.  CLINICAL MANIFESTATIONS OF GRAFT‐VERSUS-HOST DISEASE IN HUMAN RECIPIENTS OF MARROW FROM HL‐A-MATCHED SIBLING DONOR,S , 1974, Transplantation.

[55]  E. Kaplan,et al.  Nonparametric Estimation from Incomplete Observations , 1958 .